PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ANABOLIC STEROIDS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMedDate not supplied

Recent developments in the toxicology of anabolic steroids.

Anabolic steroids are extensively abused as ergogenic aids by athletes (and others). A number of features of anabolic steroid use and toxicology have been recently reviewed in the Journal, and a large body of data has accumulated concerning their toxic nature. The lipoprotein profile induced by anabolic steroids carries a markedly adverse cardiovascular risk. Glucose metabolism is significantly altered and includes peripheral insulin resistance, hyperinsulinaemia and attenuated responses to glucagon. Hypertension has been noted. Psychiatric and psychological alterations are major toxicities of anabolic steroids, and probably constitute the major mechanism of their action. Hepatic neoplasia occurs in the setting of abuse of this class of drugs, and may be related to their use, although there is no convincing evidence that other malignancies are induced in athletes who abuse them. Gross disturbance of reproductive function occurs in both sexes: hypogonadal states are common and prolonged. The anabolic steroids are toxic drugs with both long and short term effects. Their abuse by athletes is to be decried, particularly in view of the frequent and prolonged use by the young.

Anabolic Agents↗
PubMed2000

Anabolic steroids.

Anabolic steroids are synthetic derivatives of testosterone modified to enhance the anabolic rather than the androgenic actions of the hormone. The anabolic effects are considered to be those promoting protein synthesis, muscle growth and crythopoiesis. There are numerous side-effects to anabolic steroids, including hypertension and atherosclerosis, blood clotting, jaundice, hepatic carcinoma, tendon damage, psychiatric and behavioural effects and, in males, reduced fertility and gynaccomastia. Anabolic steroids were added to the International Olympic Committee's list of banned substances in 1975. The majority of 'evidence' concerning the efficacy of anabolic steroids as performance enhancing agents is anecdotal. In the main, experimental investigations have been poorly designed scientifically, clinically and statistically. The percentage of positive test results from IOC accredited laboratories has remained consistently low. However, athletes take their steroids during training and out-of-competition testing is not conducted in all countries, although international co-operation is now under consideration. Despite the lack of conclusive evidence, steroids users will continue to hold the view that their effects are efficacious and they are therefore unlikely to be persuaded to curtail their use.

Anabolic Agents↗
PubMedDate not supplied

The cardiac toxicity of anabolic steroids.

Anabolic steroids are synthetic derivatives of testosterone that were developed as adjunct therapy for a variety of medical conditions. Today they are most commonly used to enhance athletic performance and muscular development. Both illicit and medically indicated anabolic steroid use have been temporally associated with many subsequent defects within each of the body systems. Testosterone is the preferred ligand of the human androgen receptor in the myocardium and directly modulates transcription, translation, and enzyme function. Consequent alterations of cellular pathology and organ physiology are similar to those seen with heart failure and cardiomyopathy. Hypertension, ventricular remodeling, myocardial ischemia, and sudden cardiac death have each been temporally and causally associated with anabolic steroid use in humans. These effects persist long after use has been discontinued and have significant impact on subsequent morbidity and mortality. The mechanisms of cardiac disease as a result of anabolic steroid use are discussed in this review.

Anabolic Agents↗
PubMed1999

Anabolic steroids.

Anabolic steroids may be an additional mode of intervention to promote anabolism and improve clinical outcome in various acute and chronic wasting diseases. The present review discusses the rationale for anabolic steroid treatment in acute and chronic disease, their mechanistic actions, the available clinical trials in acute and chronic disease and their side-effects.

Acute Disease↗
PubMedDate not supplied

Adverse effects of anabolic steroids.

Anabolic steroids are used therapeutically for various disorders and as ergogenic aids by athletes to augment strength, muscular development, and to enhance performance. There is a wide range of concomitant temporary and permanent adverse effects with steroid administration. Several well-documented adverse actions of these hormones may develop rapidly within several weeks or less (i.e. altered reproductive function) or require up to several years of steroid intake (i.e. liver carcinoma). More recent studies indicate that glucose intolerance, insulin resistance, increased cardiovascular disease risk profiles, cerebral dangers, musculoskeletal injuries, prostate cancer, psychosis and schizophrenic episodes, among others, accompany anabolic steroid intake. There is, at present, no evidence to support the claim that athletes are less susceptible to adverse effects than those individuals receiving hormone treatment in a clinical setting. Based on the available information which has accumulated primarily from cross-sectional, short term longitudinal, and case studies, there is a need: (a) to develop a comprehensive battery of specific and sensitive markers of adverse effects, particularly those that would be able to detect the onset of adverse actions; and (b) to conduct controlled long term longitudinal studies in order to fully understand the extensiveness and mechanisms involved in the occurrence of adverse effects.

Anabolic Agents↗
PubMed1995

Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids.

Anabolic steroid use is widespread and has been associated with a variety of pathological conditions. The subject of this case is a 20-year-old amateur bodybuilder who died of sudden cardiopulmonary arrest. He had no previous medical complaints but had a history of anabolic steroid abuse and a hypertrophic heart (515 g) at autopsy. This case presentation will discuss the cardiovascular effects of these drugs and the possible impact of long-term abuse.

Adult↗
PubMed1993

Anabolic steroids.

Anabolic steroids have been employed extensively in equine practice over the past 25 years. Their usefulness is largely dependent on subjective opinions, as only minimal studies have been carried out in horses. Therefore, their use will vary markedly between practitioners depending on their personal experiences and pressures by trainers to use them. They form part of rational therapy in a variety of conditions. In addition to use for increasing muscle mass, they are used to a varying extent in the raising of yearlings and in the training and racing of horses with the view of improving performance. However, in almost all countries, the latter use is largely curtailed, and the presence of these substances in postrace urine samples constitutes use of an illegal substance. To detect the use of anabolic steroids, including testosterone, sensitive ELISA tests for screening and GC/MS for confirmation have been developed. These compounds can be used safely. Risks can be encountered if too high doses are used, as horses may become difficult to manage due to increased aggressiveness and other stallion-like behavior. Reproductive efficiency in both stallions and mares may be temporarily impaired, but this is quite rapidly reversible following cessation of treatment.

Anabolic Agents↗
PubMed2004

Cardiac effects of anabolic steroids.

Anabolic steroid abuse in athletes has been associated with a wide range of adverse conditions, including hypogonadism, testicular atrophy, impaired spermatogenesis, gynaecomastia, and psychiatric disturbance. But what effect does steroid abuse have on the cardiovascular system?

Anabolic Agents↗
PubMed1994

[Pharmacological action of anabolic steroids].

Anabolic steroids (AS) are derivatives of androgen (testosterone and its close relatives). AS have been primarily developed for clinical use as anabolic agents with the expectation that they would be relatively less androgenic than testosterone and its close relatives. Various AS are applied to clinical use, but none is free from androgenic activity. Relation between chemical structure and anabolic-androgenic potency of various AS is summarized. AS action in erythropoiesis operates through increased porphyrin formation and production of erythropoietin. Mechanism of AS action in bone formation is suggested that AS potentiate intestinal 1.25(OH)2D receptors. Identification of androgen receptors in normal human osteoblast-like cells suggest that AS act directly on receptor-mediated mechanism. The other action of AS is briefly summarized.

Anabolic Agents↗
PubMed1995

Spontaneous rupture of the anterior cruciate ligament after anabolic steroids.

Anabolic steroids remain popular among body builders and power athletes despite numerous warning about their side effects. A case of spontaneous rupture of the anterior cruciate ligament is reported in a bodybuilder taking steroids. While there are many published reports of tendon rupture associated with steroid intake, the authors could find no report relating to ligament disruption.

Adult↗
PubMed1990

Anabolic steroid abuse.

Anabolic steroids are capable of increasing strength and muscle bulk in certain individuals when combined with a proper diet and an intense training program. Any steroid that is anabolic is also androgenic. Anabolic steroids are fraught with numerous side effects, a few of which are potentially life threatening, and some of which are permanent. Most of the side effects are mild and reversible. Use of anabolic steroids in sports is as much a moral issue as a medical one. Drug testing has not been a very successful means to eradicate abuse in the sporting arena. Education alone is probably not the answer to stopping anabolic steroid abuse but is an essential first step in combating this problem. Use of anabolic steroids in athletes is a form of cheating, and use will likely continue, especially if the rewards for success in sports remain so high. Physicians should avoid condemning individuals who choose to use anabolic steroids and encourage discussion of use with their health providers.

Adolescent↗
PubMed2006

[Determination of anabolic steroid hormones in animal muscle tissues by gas chromatography/mass spectrometry].

A gas chromatography/mass spectrometry (GC/MS) method was developed for the determination of multi-residues of steroid anabolic hormones epitestosterone (ETS), testosterone 17-propionate (PTS), nandrolone (17beta-NT), 17alpha-methyltestosterone (MTS), 17beta-estradiol (17beta-ES), estriol ( EST), 17alpha-ethinylestradiol (EES), estrone (ESN) and 17beta-estradiol 3-benzoate (BES) in the muscle tissues of various animal species. Homogenized tissue samples were enzymatically digested in acetate buffer (pH 5.0). Consequently, methanol was added and the mixtures were extracted under ultrasonication incubation. Clean-up was carried out for at least two times with methyl tert-butyl ether (MTBE) liquid-liquid partitioning followed by a reversed-phase solid phase extraction (SPE) cartridge purification. The eluate with methanol was evaporated to dryness by N2 at 40 degrees C and derivatization was achieved with N-methyl-N-( trimethylsilyl) trifluoroacetamide/iodotrimethylsilane/dithioerythritol (MSTFA-TMIS-DTE) at 60 degrees C for 45 min. The reaction mixture was injected into a gas chromatograph with a DB-1 capillary column coupled with a mass spectrometer. The samples were tested by different selected ion monitoring modes with electron impact (EI) source for the androgens and estrogens. The limits of quantitation (LOQ) for the above 9 hormones were in the range of 1.0 - 2.0 microg/kg. At the 2.0 microg/kg LOQ spiked level, the mean recoveries were within 62.5% - 80.5%, and the relative standard deviations were within 12.5% - 26.8%. The real sample tests showed this method can be used for the sensitive and accurate determination of multi-steroid anabolic hormones residues in biological muscle samples.

Acetamides↗
PubMed1992

Cardiovascular implications of anabolic steroid abuse.

Anabolic steroids are synthetic derivatives of the hormone testosterone. Anabolic effects such as anticatabolism, increased skeletal muscle mass, and increased aggressiveness are usually desired; however, androgenic effects also result. Decreases in high-density lipoprotein, increases in low-density lipoprotein, changes in total serum cholesterol, hematocrit, and clotting factors, and the development of hypertensive diseases have all been implicated as resulting from anabolic steroid use. Research does not directly link anabolic steroids with cardiovascular diseases, but steroid use can significantly increase risk factors for atherosclerotic cardiovascular disease.

Anabolic Agents↗
PubMed1977

Radioimmunoassay of anabolic steroids: an evaluation of three antisera for the detection of anabolic steroids in biological fluids.

Recently developed radioimmunoassays (RIA) for the analysis of anabolic steroids and their metabolites in biological fluids were tested for cross-reactivity with other types of steroids. Results show that the degree of desirable cross-reactivity within the two classes or orally active anabolic steroids vary widely and that the antiserum for 19-Nortestosterone (the active principle of intramuscular preparations) has a very high degree of undesirable cross-reactivity with components of oral contraceptives. Single and multiple dose studies in human volunteers demonstrate that the detection level and degree of retrospectivity are likewise variable but that the test easily detects most anabolic steroids during treatment. At the present time, the combination of the three antisera for the assay of a sample appears to be a relatively rapid and economic method for screening large numbers of samples in situations where doping control of anabolic steroids is required. The importance of utilizing physico-chemical means for identification of RIA potential positives is emphasized.

Anabolic Agents↗
PubMed2006

Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.

BACKGROUND: Anabolic androgenic steroids are used by some bodybuilders to enhance performance. While the cardiovascular implications of supraphysiological androgen levels requires further clarification, use is associated with sudden death, left ventricular hypertrophy, thrombo-embolism and cerebro-vascular events. MATERIALS AND METHODS: To further understand the effect of androgenic anabolic steroid abuse on vascular function, this study assessed vascular stiffness (pulse-wave analysis) and cardiovascular risk factors in 28 male, bodybuilding subjects, of whom ten were actively receiving anabolic agents (group A; 26.4 +/- 7.2 years) and eight had undergone a 3-month "wash-out" period (group B; 32.1 +/- 7.1 years). The remaining ten bodybuilding subjects (group C; 24.4 +/- 4.4 years) denied any past use of anabolic steroids or other performance enhancing drugs. Comparisons were made with ten sedentary male controls (group D, 29.3 +/- 4.7 years). RESULTS: Endothelial independent dilatation in response to glycerol trinitrate was significantly impaired in the group currently using anabolic steroids (group A) compared with the other three groups [A (5.63 +/- 3.24%) versus; B (11.10 +/- 4.91%), C (17.88 +/- 9.2%) and D (14.46 +/- 3.9%), P < 0.0005, respectively], whereas no significant differences in endothelial-dependent dilatation were detected between the groups [A (5.0 +/- 3.0%), B (7.4 +/- 3.4%), C (9.6 +/- 4.5%) and D (8.2 +/- 3.3%), P < 0.059, respectively]. CONCLUSIONS: Previous studies described a decline in vascular reactivity occurring in bodybuilding subjects which is independent of anabolic steroid use and may result from smooth muscle hypertrophy with increased vascular stiffness. This study revealed impaired vascular reactivity associated with anabolic agents and that improvement in vascular function may occur following their discontinuation.

Administration, Sublingual↗
PubMed1992

Dying to be big: a review of anabolic steroid use.

Anabolic steroids use is commonly perceived to be the domain of the higher echelons of competitive athletes. However, a great deal of anabolic steroid use occurs in private gymnasia (non-local authority) among non-competitive recreational athletes. Our study has attempted to give an insight into the prevalence of the use of these drugs, the hazards associated with it, and the public health responses which we have adopted.

Adult↗